应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
APLM Apollomics Inc
休市中 02-13 16:00:00 EST
19.79
+0.59
+3.07%
盘后
19.79
+0.00
0.00%
17:11 EST
最高
20.78
最低
19.09
成交量
7,438
今开
19.09
昨收
19.20
日振幅
8.80%
总市值
4,242万
流通市值
3,591万
总股本
214.33万
成交额
14.64万
换手率
0.41%
流通股本
181.46万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
冠科美博盘中异动 股价大跌5.03%报18.50美元
市场透视 · 02-06
冠科美博盘中异动 股价大跌5.03%报18.50美元
Apollomics:公司预计终止不会对其整体财务状况或经营成果产生重大不利影响
美股速递 · 2025-12-13
Apollomics:公司预计终止不会对其整体财务状况或经营成果产生重大不利影响
Apollomics:因爱迪生未能履行某些重要的业绩与报告义务而终止协议
美股速递 · 2025-12-13
Apollomics:因爱迪生未能履行某些重要的业绩与报告义务而终止协议
Apollomics于12月11日向Edison Oncology正式发布终止通知,涉及Apl-122的开发与商业化
美股速递 · 2025-12-13
Apollomics于12月11日向Edison Oncology正式发布终止通知,涉及Apl-122的开发与商业化
冠科美博盘中异动 股价大涨17.85%报17.96美元
市场透视 · 2025-11-28
冠科美博盘中异动 股价大涨17.85%报17.96美元
Apollomics达成与两名少数投资者相关法律诉讼的和解协议
美股速递 · 2025-11-20
Apollomics达成与两名少数投资者相关法律诉讼的和解协议
冠科美博盘中异动 快速拉升7.19%
市场透视 · 2025-11-11
冠科美博盘中异动 快速拉升7.19%
冠科美博盘中异动 早盘股价大涨20.33%报13.97美元
市场透视 · 2025-10-31
冠科美博盘中异动 早盘股价大涨20.33%报13.97美元
冠科美博盘中异动 早盘快速下跌11.13%报12.54美元
市场透视 · 2025-10-30
冠科美博盘中异动 早盘快速下跌11.13%报12.54美元
冠科美博盘中异动 急速跳水11.28%报25.03美元
市场透视 · 2025-10-24
冠科美博盘中异动 急速跳水11.28%报25.03美元
冠科美博盘中异动 股价大涨5.38%报20.55美元
市场透视 · 2025-10-16
冠科美博盘中异动 股价大涨5.38%报20.55美元
Apollomics - 纳斯达克取消该公司的上诉听证会;证券继续上市并在纳斯达克交易
美股速递 · 2025-10-16
Apollomics - 纳斯达克取消该公司的上诉听证会;证券继续上市并在纳斯达克交易
Apollomics Inc预期将尽快终止Sparta临床试验的所有相关活动
美股速递 · 2025-08-28
Apollomics Inc预期将尽快终止Sparta临床试验的所有相关活动
冠科美博盘中异动 临近午盘股价大涨7.03%
市场透视 · 2025-08-11
冠科美博盘中异动 临近午盘股价大涨7.03%
冠科美博盘中异动 早盘股价大涨6.42%报6.80美元
市场透视 · 2025-03-10
冠科美博盘中异动 早盘股价大涨6.42%报6.80美元
冠科美博盘中异动 早盘股价大涨6.94%
市场透视 · 2025-03-03
冠科美博盘中异动 早盘股价大涨6.94%
冠科美博盘中异动 早盘股价大跌5.57%报6.54美元
市场透视 · 2025-02-28
冠科美博盘中异动 早盘股价大跌5.57%报6.54美元
冠科美博盘中异动 股价大涨6.47%
市场透视 · 2025-02-27
冠科美博盘中异动 股价大涨6.47%
冠科美博盘中异动 早盘大幅下跌7.00%报6.51美元
市场透视 · 2025-02-26
冠科美博盘中异动 早盘大幅下跌7.00%报6.51美元
冠科美博盘中异动 大幅下跌6.58%
市场透视 · 2025-02-21
冠科美博盘中异动 大幅下跌6.58%
暂无数据
公司概况
公司名称:
Apollomics Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
冠科美博有限公司于2015年5月21日在开曼群岛注册成立。他们是一家创新的临床阶段生物技术公司,专注于发现和开发肿瘤疗法,以满足未满足的医疗需求。自2015年成立以来,他们已经在11个专注于肿瘤学的项目中建立了一个包含9种候选药物的管道,其中6种候选药物处于临床阶段。
发行价格:
--
{"stockData":{"symbol":"APLM","market":"US","secType":"STK","nameCN":"Apollomics Inc","latestPrice":19.79,"timestamp":1771016400000,"preClose":19.2,"halted":0,"volume":7438,"hourTrading":{"tag":"盘后","latestPrice":19.79,"preClose":19.79,"latestTime":"17:11 EST","volume":7,"amount":138.64,"timestamp":1771020673615,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03072916666666666,"floatShares":1814600,"shares":2143300,"eps":-28.29631,"marketStatus":"休市中","change":0.59,"latestTime":"02-13 16:00:00 EST","open":19.09,"high":20.78,"low":19.09,"amount":146442.006804,"amplitude":0.088021,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-28.29631,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":19.2,"preHourTrading":{"tag":"盘前","latestPrice":19,"preClose":19.2,"latestTime":"08:00 EST","volume":1,"amount":19,"timestamp":1770987605856,"change":-0.2,"changeRate":-0.010417,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":19.79,"preClose":19.79,"latestTime":"17:11 EST","volume":7,"amount":138.64,"timestamp":1771020673615,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.40979813275111676},"requestUrl":"/m/hq/s/APLM/tweets","defaultTab":"tweets","newsList":[{"id":"2609583750","title":"冠科美博盘中异动 股价大跌5.03%报18.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609583750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609583750?lang=zh_cn&edition=full","pubTime":"2026-02-06 02:13","pubTimestamp":1770315226,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日02时13分,冠科美博股票出现波动,股价急速下跌5.03%。截至发稿,该股报18.50美元/股,成交量7550股,换手率0.35%,振幅2.36%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。冠科美博股票所在的生物技术行业中,整体跌幅为0.77%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020602134697a51355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020602134697a51355&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"1103199123","title":"Apollomics:公司预计终止不会对其整体财务状况或经营成果产生重大不利影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1103199123","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103199123?lang=zh_cn&edition=full","pubTime":"2025-12-13 00:41","pubTimestamp":1765557670,"startTime":"0","endTime":"0","summary":"Apollomics:公司预计终止不会对其整体财务状况或经营成果产生重大不利影响","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"1120613943","title":"Apollomics:因爱迪生未能履行某些重要的业绩与报告义务而终止协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1120613943","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120613943?lang=zh_cn&edition=full","pubTime":"2025-12-13 00:39","pubTimestamp":1765557566,"startTime":"0","endTime":"0","summary":"Apollomics:因爱迪生未能履行某些重要的业绩与报告义务而终止协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"1199157602","title":"Apollomics于12月11日向Edison Oncology正式发布终止通知,涉及Apl-122的开发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1199157602","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199157602?lang=zh_cn&edition=full","pubTime":"2025-12-13 00:38","pubTimestamp":1765557516,"startTime":"0","endTime":"0","summary":"Apollomics于12月11日向Edison Oncology正式发布终止通知,涉及Apl-122的开发与商业化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2587368751","title":"冠科美博盘中异动 股价大涨17.85%报17.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2587368751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2587368751?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:43","pubTimestamp":1764341031,"startTime":"0","endTime":"0","summary":"北京时间2025年11月28日22时43分,冠科美博股票出现异动,股价快速上涨17.85%。截至发稿,该股报17.96美元/股,成交量566股,换手率0.03%,振幅0.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。冠科美博股票所在的生物技术行业中,整体跌幅为0.10%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128224352978501ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251128224352978501ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":1},{"id":"1199023344","title":"Apollomics达成与两名少数投资者相关法律诉讼的和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1199023344","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199023344?lang=zh_cn&edition=full","pubTime":"2025-11-20 05:08","pubTimestamp":1763586499,"startTime":"0","endTime":"0","summary":"Apollomics达成与两名少数投资者相关法律诉讼的和解协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2582878543","title":"冠科美博盘中异动 快速拉升7.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582878543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582878543?lang=zh_cn&edition=full","pubTime":"2025-11-11 02:11","pubTimestamp":1762798291,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日02时11分,冠科美博股票出现波动,股价急速上涨7.19%。截至发稿,该股报15.20美元/股,成交量7501股,换手率0.35%,振幅9.20%。冠科美博股票所在的生物技术行业中,整体涨幅为0.51%。冠科美博公司简介:冠科美博有限公司是一家临床阶段的创新型生物制药公司,致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法,利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111102113194fbdf5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111102113194fbdf5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLTO","APLM"],"gpt_icon":0},{"id":"2580428494","title":"冠科美博盘中异动 早盘股价大涨20.33%报13.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580428494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580428494?lang=zh_cn&edition=full","pubTime":"2025-10-31 22:07","pubTimestamp":1761919622,"startTime":"0","endTime":"0","summary":"北京时间2025年10月31日22时07分,冠科美博股票出现异动,股价快速拉升20.33%。截至发稿,该股报13.97美元/股,成交量1254股,换手率0.06%,振幅0.00%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-53.86百万美元,每股收益-52.80美元,毛利-361000.00美元,市盈率-0.26倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。冠科美博股票所在的生物技术行业中,整体跌幅为0.07%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031220702a4802f20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031220702a4802f20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2579312199","title":"冠科美博盘中异动 早盘快速下跌11.13%报12.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579312199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579312199?lang=zh_cn&edition=full","pubTime":"2025-10-30 21:32","pubTimestamp":1761831125,"startTime":"0","endTime":"0","summary":"北京时间2025年10月30日21时32分,冠科美博股票出现波动,股价快速跳水11.13%。截至发稿,该股报12.54美元/股,成交量3693股,换手率0.17%,振幅12.69%。冠科美博股票所在的生物技术行业中,整体跌幅为1.28%。冠科美博公司简介:冠科美博有限公司是一家临床阶段的创新型生物制药公司,致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法,利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030213205a47dfc9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030213205a47dfc9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2578575542","title":"冠科美博盘中异动 急速跳水11.28%报25.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2578575542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578575542?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:31","pubTimestamp":1761312677,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日21时31分,冠科美博股票出现异动,股价大幅下挫11.28%。截至发稿,该股报25.03美元/股,成交量1220股,换手率0.06%,振幅0.00%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-53.86百万美元,每股收益-52.80美元,毛利-361000.00美元,市盈率-0.51倍。冠科美博股票所在的生物技术行业中,整体涨幅为0.40%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213118a6cc2f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024213118a6cc2f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2576900084","title":"冠科美博盘中异动 股价大涨5.38%报20.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576900084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576900084?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:31","pubTimestamp":1760621517,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时31分,冠科美博股票出现波动,股价快速上涨5.38%。截至发稿,该股报20.55美元/股,成交量1.6554万股,换手率0.77%,振幅1.90%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-53.86百万美元,每股收益-52.80美元,毛利-361000.00美元,市盈率-0.39倍。冠科美博股票所在的生物技术行业中,整体涨幅为0.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213157a6bd1f7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213157a6bd1f7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"1169891245","title":"Apollomics - 纳斯达克取消该公司的上诉听证会;证券继续上市并在纳斯达克交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1169891245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169891245?lang=zh_cn&edition=full","pubTime":"2025-10-16 02:38","pubTimestamp":1760553490,"startTime":"0","endTime":"0","summary":"Apollomics - 纳斯达克取消该公司的上诉听证会;证券继续上市并在纳斯达克交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"1199180126","title":"Apollomics Inc预期将尽快终止Sparta临床试验的所有相关活动","url":"https://stock-news.laohu8.com/highlight/detail?id=1199180126","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199180126?lang=zh_cn&edition=full","pubTime":"2025-08-28 18:32","pubTimestamp":1756377138,"startTime":"0","endTime":"0","summary":"Apollomics Inc表示,预期将尽快停止与Sparta临床试验相关的所有活动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2558661523","title":"冠科美博盘中异动 临近午盘股价大涨7.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661523?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:32","pubTimestamp":1754926321,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时32分,冠科美博股票出现异动,股价大幅拉升7.03%。截至发稿,该股报6.07美元/股,成交量4.0829万股,换手率3.70%,振幅0.00%。冠科美博股票所在的生物技术行业中,整体涨幅为0.25%。冠科美博公司简介:冠科美博有限公司是一家临床阶段的创新型生物制药公司,致力于发现和开发具有与其他治疗方案相结合潜力的肿瘤疗法,利用免疫系统和靶向特定分子通路抑制癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811233201a4824145&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811233201a4824145&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2518273479","title":"冠科美博盘中异动 早盘股价大涨6.42%报6.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518273479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518273479?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:05","pubTimestamp":1741615531,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时05分,冠科美博股票出现异动,股价急速上涨6.42%。截至发稿,该股报6.80美元/股,成交量356股,换手率0.03%,振幅1.72%。最近的财报数据显示,该股实现营业收入0.00美元,净利润-35.21百万美元,每股收益-0.38美元,毛利-199000.00美元,市盈率-0.43倍。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。冠科美博股票所在的生物技术行业中,整体涨幅为0.00%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220531a26a31bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220531a26a31bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0},{"id":"2516263464","title":"冠科美博盘中异动 早盘股价大涨6.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516263464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516263464?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:37","pubTimestamp":1741012634,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时37分,冠科美博股票出现异动,股价大幅拉升6.94%。截至发稿,该股报6.63美元/股,成交量337股,换手率0.03%,振幅0.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。冠科美博股票所在的生物技术行业中,整体涨幅为0.08%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223714989a10eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223714989a10eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":1},{"id":"2514465382","title":"冠科美博盘中异动 早盘股价大跌5.57%报6.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514465382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514465382?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:10","pubTimestamp":1740672617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时10分,冠科美博股票出现波动,股价大幅下挫5.57%。截至发稿,该股报6.54美元/股,成交量44股,换手率0.00%,振幅0.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。冠科美博股票所在的生物技术行业中,整体涨幅为0.62%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280010179632c614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280010179632c614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2514862351","title":"冠科美博盘中异动 股价大涨6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862351?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:11","pubTimestamp":1740600662,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时11分,冠科美博股票出现异动,股价急速上涨6.47%。截至发稿,该股报6.93美元/股,成交量452股,换手率0.04%,振幅0.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。冠科美博股票所在的生物技术行业中,整体跌幅为0.78%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041102a255422c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227041102a255422c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":0},{"id":"2514019208","title":"冠科美博盘中异动 早盘大幅下跌7.00%报6.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514019208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514019208?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:20","pubTimestamp":1740500401,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时20分,冠科美博股票出现异动,股价快速下跌7.00%。截至发稿,该股报6.51美元/股,成交量403股,换手率0.04%,振幅7.00%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。冠科美博股票所在的生物技术行业中,整体涨幅为0.59%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002001a2539fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226002001a2539fba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APLM","BK4139"],"gpt_icon":1},{"id":"2513296851","title":"冠科美博盘中异动 大幅下跌6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296851?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:41","pubTimestamp":1740148906,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时41分,冠科美博股票出现波动,股价大幅下跌6.58%。截至发稿,该股报7.10美元/股,成交量661股,换手率0.06%,振幅0.00%。冠科美博股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Nkgen Biotech, Inc.涨幅较大,Nkgen Biotech, Inc.、Aditxt, Inc.、Windtree Therapeutics, Inc.较为活跃,换手率分别为77.47%、70.02%、25.00%,振幅较大的相关个股有Osr Holdings Inc C/Wts 09/02/2028 、Omega Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 ,振幅分别为46.92%、35.45%、33.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224146962b7dee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224146962b7dee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APLM"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.apollomicsinc.com","stockEarnings":[{"period":"1week","weight":0.0281},{"period":"1month","weight":-0.0015},{"period":"3month","weight":-0.1936},{"period":"6month","weight":2.4903},{"period":"1year","weight":1.7601},{"period":"ytd","weight":0.0586}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"冠科美博有限公司于2015年5月21日在开曼群岛注册成立。他们是一家创新的临床阶段生物技术公司,专注于发现和开发肿瘤疗法,以满足未满足的医疗需求。自2015年成立以来,他们已经在11个专注于肿瘤学的项目中建立了一个包含9种候选药物的管道,其中6种候选药物处于临床阶段。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.103319},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.088159},{"month":3,"riseRate":0.5,"avgChangeRate":0.000668},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.392454},{"month":5,"riseRate":0,"avgChangeRate":-0.167326},{"month":6,"riseRate":0.666667,"avgChangeRate":0.065872},{"month":7,"riseRate":0,"avgChangeRate":-0.08916},{"month":8,"riseRate":0,"avgChangeRate":-0.25605},{"month":9,"riseRate":0.666667,"avgChangeRate":1.207119},{"month":10,"riseRate":0,"avgChangeRate":-0.397453},{"month":11,"riseRate":0.666667,"avgChangeRate":0.002362},{"month":12,"riseRate":1,"avgChangeRate":0.119621}],"exchange":"NASDAQ","name":"Apollomics Inc","nameEN":"Apollomics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apollomics Inc(APLM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apollomics Inc(APLM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apollomics Inc,APLM,Apollomics Inc股票,Apollomics Inc股票老虎,Apollomics Inc股票老虎国际,Apollomics Inc行情,Apollomics Inc股票行情,Apollomics Inc股价,Apollomics Inc股市,Apollomics Inc股票价格,Apollomics Inc股票交易,Apollomics Inc股票购买,Apollomics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apollomics Inc(APLM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apollomics Inc(APLM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}